Search is Powered by Google
Pharma Industry / Biotech Industry News

French Biotech Crop Decision Environmentally Unfriendly

Main Category: Pharma Industry / Biotech Industry
Article Date: 15 Jan 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The French Government's decision to invoke the safeguard clause on biotech maize contradicts the conclusions of the French Environment Round Table (Grenelle de l'Environnement) and government policy on ecological and sustainable development.

"In addition, the Government bases its decision on 'serious doubts' about biotech crops but we have serious doubts about the process that has led to this decision," says Nathalie Moll, Executive Director, EuropaBio - the EU association for bioindustries. The report from the provisional High Authority - compiled in a couple of weeks - states itself that there was not sufficient time to review all the literature. Furthermore, 12 of the High Authority's 15 scientists disagree with the Authority's conclusions and said that they never found evidence for serious doubts or negative consequences concerning GM crops, plus 2 of the "socio-economic experts", which makes a total of 14 experts from the High Authority, are criticizing the way the conclusions are worded.

The biotech maize concerned has been the subject of thorough scientific reviews by scientific communities around the world and has received approvals within the world's most robust approval systems. The maize has been used and consumed by millions of people and animals without a single reported incidence of harm to anyone. The biotech maize has also received positive scientific reviews by the EFSA and has had a full approval in the EU since 1998. The maize product has also been approved in 13 other countries around the world.

France is Europe's largest maize grower and suspension of biotech maize plantings will intensify the environmental footprint of maize production in France by increasing the amount of fuel consumption and CO² emissions. In 2007, French farmers grew almost 22 000 hectares of Bt maize. This equates to a saving of 29 000 litres of fuel, 8 800 litres of insecticide and 86 500 kg of CO², whilst increasing maize production by 25 000 tonnes. Growing GM maize thus boosted French farmers' income by € 1.5 million.

About EuropaBio

EuropaBio is the European Association for Bioindustries, solely and uniquely bringing together bioscience companies from all fields of research and development, testing, manufacturing and distribution of biotechnology products. It has 85 corporate members operating worldwide, 7 associate members, 5 BioRegions and 25 national biotechnology associations representing some 1800 small and medium sized enterprises involved in research.

EuropaBio

Ad Banner - Excellence in Epilepsy Journalism Award - 3 prizes in travel vouchers


Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
U.S. FDA Approves Requip® XL™, The First And Only Oral Once-daily Non-ergot Dopamine Agonist For Parkinson's Disease
15 Jun 2008
GlaxoSmithKline announced the approval of Requip® XL™(ropinirole extended-release tablets) in the U.S. for the treatment of the signs and symptoms of idiopathic Parkinson's disease...


When the Pain Just Won't Go Away
When the Pain Just Won't Go Away

If pain lingers for months and interferes with your life, chances are you are dealing with chronic pain. Depression and anxiety often go along with chronic pain. Getting a proper diagnosis is the first step to treating it successfully.

more videos are available in our health videos section.